Viewing Study NCT00393354



Ignite Creation Date: 2024-05-05 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00393354
Status: COMPLETED
Last Update Posted: 2022-02-18
First Post: 2006-10-26

Brief Title: Effect of Etoricoxib to Treat Chronic Low Back Pain 0663-041
Sponsor: Organon and Co
Organization: Organon and Co

Study Overview

Official Title: A Double-Blind Placebo-Controlled Parallel-Group 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2006_548 None None None